Scienture Holdings, Inc. - Common Stock SCNX 深 滬
等待開盤 07-26 09:30:00 美东时间
1.99
-0.040
-1.97%
華盛通- 最 高2.04
- 今 開2.02
- 成交量 17.15万股
- 最 低 1.90
- 昨 收 2.03
- 總市值 2610.16万
- 52周最高 10.23
- 市盈率 靜 --
- 換手率 1.31%
- 52周最低 0.69
- 委 比 73.92%
- 總股本 1311.64万
- 歷史最高 164.50
- 量 比 0.74
- 振 幅 6.90%
- 歷史最低 -5.81
- 每 手 1
- 風險率 3.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Scienture Holdings Secures $1.2 Million in Capital Raise
Scienture Holdings ( ($SCNX) ) has issued an announcement. On July 24, 2025, Sc...
07-25 05:49
Scienture secures $1.2 million in bridge funding
Scienture (NASDAQ:SCNX) has approved a bridge funding raise of up to an aggregate amount of $3M, of which it has secured about $1.2M, through the issuance of shares of the company’s common stock to in...
07-25 05:27
Scienture Holdings' Boards Of Directors Approve A Bridge Funding Raise Of Up To An Aggregate Amount Of $3M, Of Which It Has Secured ~ $1.2M
Commack, NY, July 24, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) (the "Company") a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value
07-25 05:15
Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding
Sciencure Holdings Inc. (NASDAQ: SCNX) announced that its board of directors approved a bridge funding raise of up to $3 million, with $1.2 million secured through issuing common stock to institutional or accredited investors. The funding does not include warrants, options, or other convertible securities, reflecting strong investor support. The funds will be used to support upcoming product launches and pipeline development. Executives expressed...
07-24 21:12
Scienture Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements
SCIENTURE HOLDINGS, INC. announced it has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its stock price closed at $1.00 per share or higher for ten consecutive business days. The company had previously been notified on May 19, 2025, of non-compliance due to its stock price falling below the required threshold. Compliance was achieved within the 180-day grace period provided by Nasdaq. The company expressed satisfaction with its te...
07-16 12:15
Scienture Holdings Secures Indemnification for Leadership
Scienture Holdings ( ($SCNX) ) has shared an update. On June 27, 2025, Scientur...
07-04 05:33
Scienture Holdings Terminates Equity Line Of Credit Facility Effective As Of May 22, 2025
SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) (the "Company"), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through
06-17 20:11
Scienture Holdings Announces Cancelation of ELOC
SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) has terminated its Equity Line of Credit (ELOC) facility effective May 22, 2025, and filed a post-effective amendment deregistering 310,488 unsold shares. The decision to cancel the ELOC allows the Company to focus on the upcoming commercial launch of Arbli™, its first FDA-approved product, a ready-to-use oral liquid losartan. The launch is expected in Q3 2025. Arbli™ treats hypertension, reduces stroke ris...
06-17 12:05
Scienture appoints Hariharan, Mani as co-CEOs
Scienture Holdings (NASDAQ:SCNX) has announced that Suren Ajjarapu, who has served as CEO and Chairman of the Board of Directors, has stepped down from his roles with the Co., with those positions bei...
05-22 20:37
Scienture Holdings Releases Annual Letter To Shareholders
AMPA, FL, April 03, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ:SCNX) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients,
04-03 20:33
